Atlas Trials

Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus

Clinical trial NCT03413722 · COMPLETED

Trial details

NCT number
NCT03413722
Sponsor
University of Kansas Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
End Stage Renal Disease
Start date
2018-02-01
Primary completion
2021-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.